Matinas BioPharma Holdings, Inc. Stock price
Equities
MTNB
US5768101058
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.271 USD | -6.52% | +1.80% | +25.35% |
Mar. 27 | Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 62.98M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.52
x | P/E ratio 2025 * |
-2.9
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.08% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | +1.47% | ||
1 week | +0.66% | ||
Current month | +3.50% | ||
1 month | +8.33% | ||
3 months | +19.30% | ||
6 months | +120.12% | ||
Current year | +34.09% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.271 | -6.52% | 1 205 189 |
24-03-27 | 0.2899 | +1.47% | 1,038,009 |
24-03-26 | 0.2857 | -1.55% | 1,186,869 |
24-03-25 | 0.2902 | +4.39% | 3,064,437 |
24-03-22 | 0.278 | +4.43% | 22,244,560 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.09% | 62.98M | |
+9.16% | 45.97B | |
+53.58% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |